MELINTA THERAPEUTICS, INC. /NEW/ — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/faee69ee-751e-4941-8fea-a41019d3254f/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2018 | $96.4M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-002907 |
| FY 2017 | $33.9M | 2017-01-01 – 2017-12-31 | evidence 0001628280-19-002907 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001628280-19-002907 |
| FY 2015 | $27.3M | 2015-01-01 – 2015-12-31 | evidence 0001564590-17-002719 |
| FY 2014 | $15.2M | 2014-01-01 – 2014-12-31 | evidence 0001564590-17-002719 |
| FY 2013 | $7.8M | 2013-01-01 – 2013-12-31 | evidence 0001564590-14-000446 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MELINTA THERAPEUTICS, INC. /NEW/ — all facts · Net Income · Operating Income